A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Clinical trial NCT04787289 · RECRUITING
Trial details
- NCT number
- NCT04787289
- Sponsor
- British Columbia Cancer Agency
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2025-01-31
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.